HUTCHMED (China) Ltd

NASDAQ:HCMUnited States

HUTCHMED (China) Ltd is an investment holding company principally engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through two segments. Oncology Immunology segment is engaged in the discovery, development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Among it, research and development (R&D) includes research and development activities covering drug discovery, development, manufacturing and regulatory functions, out-licensing of in-house developed drugs, as well as administrative activities to support research and development operations, marketed products comprises the invoiced sales, marketing, manufacture and distribution of drugs developed from research and development activities. Other Ventures segment is engaged in the other commercial businesses which include the sales, marketing, manufacture and distribution of other prescription drugs and healthcare products.

Contact Information

Headquarters

48Th Floor, Cheung Kong Center 2 Queen's Road Central, Hong Kong

Phone

---

Fax

---

Executives

Non-Executive Chairman of the Board

Dan Eldar

Chief Executive Officer, Chief Scientific Officer, Executive Director

Weiguo Su

Chief Financial Officer, Executive Director

Chig Fung Cheng

Chief Operating Officer, Executive Vice President

Karen Atkin

Executive Vice President and Chief Commercial Officer, China

Hong Chen